By engaging two pathways simultaneously, tirzepatide may enhance appetite suppression, improve insulin sensitivity, and boost metabolic rate more powerfully than single-action agents
Weeks 13 to 16: the 1.7 mg phase (Wegovy protocol) If you are following the Wegovy weight loss protocol, the dose continues climbing
Published 2025
When something didnt feel right, whether it was nausea, fatigue, or a sense that their dose wasnt quite working, they werent sure who to ask or whether their concerns were even worth bringing up
Parkinsons disease: Trials ongoing All-Cause Mortality: Overall death rate: 10-15% reduction in high-risk populations
Mounjaro and Hair Loss SURMOUNT studies confirm that 4-5% of patients experience some form of hair loss, with higher occurrences among women, compared with about 1% on placebo